| Identifiers | |
|---|---|
| |
| PubChem CID | |
| ChemSpider | |
| Chemical and physical data | |
| Formula | C21H24BrN3O |
| Molar mass | 414.347 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Spirobrorphine is a synthetic opioid chemical compound which has been sold as a designer drug, first reported in the USA in February 2026. It was added to Schedule V of the Controlled Drugs and Substances Act in Canada in June 2026. Its pharmacology has not yet been studied but it is believed to be a potent opioid narcotic in a similar manner to related compounds such as spirochlorphine and R6372.